A META-ANALYSIS OF THE EFFECT OF STRONTIUM RANELATE ON THE RISK OF VERTEBRAL AND NON-VERTEBRAL FRACTURE IN POSTMENOPAUSAL OSTEOPOROSIS: THE IMPACT OF SEVERE OSTEOPOROSIS AND CONTRAINDICATIONS

被引:0
|
作者
Kanis, J. A. [1 ]
Johansson, H. [1 ]
Oden, A. [1 ]
McCloskey, E. V. [1 ]
Cooper, C. [2 ]
Rizzoli, R. [3 ]
Reginster, J-Y [4 ,5 ]
机构
[1] Univ Sheffield, WHO Collaborating Ctr Metab Bone Dis, Sheffield, S Yorkshire, England
[2] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England
[3] Univ Hosp & Fac Med Geneva, Geneva, Switzerland
[4] Univ Liege, Dept Publ Hlth Epidemiol & Hlth Econ, Liege, Belgium
[5] Univ Liege, HEC Sch Management, Liege, Belgium
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OC25
引用
收藏
页码:S120 / S121
页数:2
相关论文
共 50 条
  • [1] A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
    J. A. Kanis
    H. Johansson
    A. Oden
    E. V. McCloskey
    [J]. Osteoporosis International, 2011, 22 : 2347 - 2355
  • [2] A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
    Kanis, J. A.
    Johansson, H.
    Oden, A.
    McCloskey, E. V.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 (08) : 2347 - 2355
  • [3] Erratum to: A meta-analysis of the effect of strontium ranelate on the risk of vertebral and non-vertebral fracture in postmenopausal osteoporosis and the interaction with FRAX®
    J. A. Kanis
    H. Johansson
    A. Oden
    E. V. McCloskey
    [J]. Osteoporosis International, 2011, 22 (8) : 2357 - 2358
  • [4] Strontium ranelate and non-vertebral fracture in postmenopausal osteoporosis
    Callejas Rubio, Jose Luis
    Lopez Perez, Lourdes
    Sanchez Cano, Daniel
    Ortego Centeno, Norberto
    [J]. MEDICINA CLINICA, 2006, 127 (07): : 279 - 279
  • [5] Strontium ranelate reduces the risk of vertebral and non-vertebral fractures in Caucasian women with postmenopausal osteoporosis
    Adami, S
    Meunier, PJ
    Devogelaer, JP
    Hoszowski, K
    Fardellone, P
    Benhamou, V
    Brixen, K
    Bonidan, O
    Marcelli, C
    Reginster, JY
    Fechtenbaum, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S93 - S94
  • [6] Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
    Roux, C.
    Isaia, G.
    Andia, J. B. Cannata
    Devogelaer, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 681 - 681
  • [7] Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
    Roux, C.
    Fechtenbaum, J.
    Kolta, S.
    Isaia, G.
    Andia, J. B. Cannata
    Devogelaer, J-P
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (12) : 1736 - 1738
  • [8] Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis
    Devogelaer, J. P.
    Roux, C.
    Isaia, G.
    Andia, J. B. Cannata
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S335 - S335
  • [9] STRONTIUM RANELATE REDUCES THE RISK OF POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS FOR NON-VERTEBRAL FRACTURES - TROPOS (TREATMENT OF PERIPHERAL OSTEOPOROSIS)
    Mazhar, R.
    [J]. JOURNAL FUR MINERALSTOFFWECHSEL, 2005, 12 (03): : 82 - 82
  • [10] Strontium ranelate reduces the vertebral fracture risk in women with postmenopausal osteoporosis
    Meunier, PJ
    Roux, C
    Ortolani, S
    Badurski, J
    Kaufman, JM
    Spector, T
    Diez-Perez, A
    Seeman, E
    Lemmel, E
    Balogh, A
    Pors-Nielsen, S
    Phenekos, C
    Rizzoli, R
    Slosman, D
    Tupinon-Mathieu, I
    Reginster, JY
    [J]. OSTEOPOROSIS INTERNATIONAL, 2002, 13